Android app on Google Play

Goldman Sachs Downgrades Team Health (TMH) to Buy

June 16, 2014 7:48 AM EDT Send to a Friend
Get Alerts TMH Hot Sheet
Price: $53.24 +0.08%

Rating Summary:
    5 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 35 | Down: 23 | New: 13
Trade TMH Now!
Join SI Premium – FREE

Goldman Sachs downgraded Team Health (NYSE: TMH) from Conviction Buy to Buy with a price target of $59.00 (from $56.00).

Analyst Brian Zimmerman said, "While we reiterate our Buy rating and remain positive on TMH’s strong business model and position within the physician management space, after nearly 13 months we are removing the shares from the Americas Conviction List as consensus and our estimates have converged (GS +1.4% above 2015 consensus EBITDA)."

For an analyst ratings summary and ratings history on Team Health click here. For more ratings news on Team Health click here.

Shares of Team Health closed at $49.84 yesterday.





You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Downgrades

Related Entities

Goldman Sachs Conviction Buy List

Add Your Comment